ResearcherCharles UniversityActive in the last 2 years
Jan Škrha
Matched on ORCID iD 0000-0001-5388-8259; OpenAlex author ID A5003664706. Sources: OpenAlex.
Their work
- Papers
- 10 (first author 2, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 16
2015: 1 paper · 2016: 4 papers · 2017: 2 papers · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper · 2023: 1 paper · 2024: none · 2025: none · 2026: 1 paper
Papers 10
- Prevalence of new onset diabetes mellitus among patients with pancreatic ductal adenocarcinoma: a population-based study Co-author DOI 10.64898/2026.08.05.26359758↗
- Diabetes Mellitus in Pancreatic Cancer: A Distinct Approach to Older Subjects with New-Onset Diabetes Mellitus. Co-author DOI 10.3390/cancers15143669↗
- Lipidomic profiling of human serum enables detection of pancreatic cancer. Co-author DOI 10.1038/s41467-021-27765-9↗
- Precursors of pancreatic cancer. First author DOI 10.1097/meg.0000000000000810↗
- Early detection of sporadic pancreatic cancer: time for change. Co-author DOI 10.1097/meg.0000000000000904↗
- Serum microRNA-196 and microRNA-200 in pancreatic ductal adenocarcinoma of patients with diabetes mellitus. Co-author DOI 10.1016/j.pan.2016.05.005↗
- Increased tissue and circulating levels of dipeptidyl peptidase-IV enzymatic activity in patients with pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.pan.2016.06.001↗
- Early detection of pancreatic cancer: impact of high-resolution imaging methods and biomarkers. First author DOI 10.1097/meg.0000000000000727↗
- [Early detection of sporadic pancreatic cancer]. Co-author PMID 26898791↗
- [miRNA-192, miRNA-21 and miRNA-200: new pancreatic cancer markers in diabetic patients?]. Last author PMID 25894267↗
Closest collaborators
The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Miroslav Zavoral · 7 shared papers, 2016–2026 · strength 0.78
- Paper Prevalence of new onset diabetes mellitus among patients with pancreatic ductal adenocarcinoma: a population-based study DOI 10.64898/2026.08.05.26359758↗
- Paper Diabetes Mellitus in Pancreatic Cancer: A Distinct Approach to Older Subjects with New-Onset Diabetes Mellitus. DOI 10.3390/cancers15143669↗
- Paper Precursors of pancreatic cancer. DOI 10.1097/meg.0000000000000810↗
- Pavel Škrha · 7 shared papers, 2015–2023 · strength 0.62
- Paper Diabetes Mellitus in Pancreatic Cancer: A Distinct Approach to Older Subjects with New-Onset Diabetes Mellitus. DOI 10.3390/cancers15143669↗
- Paper Lipidomic profiling of human serum enables detection of pancreatic cancer. DOI 10.1038/s41467-021-27765-9↗
- Paper Early detection of sporadic pancreatic cancer: time for change. DOI 10.1097/meg.0000000000000904↗
- Jan Bureš · 2 shared papers, 2023–2026 · strength 0.46
- Paper Prevalence of new onset diabetes mellitus among patients with pancreatic ductal adenocarcinoma: a population-based study DOI 10.64898/2026.08.05.26359758↗
- Paper Diabetes Mellitus in Pancreatic Cancer: A Distinct Approach to Older Subjects with New-Onset Diabetes Mellitus. DOI 10.3390/cancers15143669↗
- Bohuš Bunganič · 5 shared papers, 2016–2023 · strength 0.43
- Premysl Fric · 6 shared papers, 2016–2017 · strength 0.38
- Paper Precursors of pancreatic cancer. DOI 10.1097/meg.0000000000000810↗
- Paper Early detection of sporadic pancreatic cancer: time for change. DOI 10.1097/meg.0000000000000904↗
- Paper Serum microRNA-196 and microRNA-200 in pancreatic ductal adenocarcinoma of patients with diabetes mellitus. DOI 10.1016/j.pan.2016.05.005↗
- Aleksi Šedo · 5 shared papers, 2016–2017 · strength 0.31
- Petr Bušek · 5 shared papers, 2016–2017 · strength 0.31
- Ondřej Májek · 1 shared paper, 2026 · strength 0.27
- Michal Anděl · 2 shared papers, 2015–2016 · strength 0.14
- Bohuslav Melichar · 1 shared paper, 2022 · strength 0.11
- Ondřej Peterka · 1 shared paper, 2022 · strength 0.11
- Denise Wolrab · 1 shared paper, 2022 · strength 0.11
- Petr Karásek · 1 shared paper, 2022 · strength 0.11
- Michal Holčapek · 1 shared paper, 2022 · strength 0.11
- Tomáš Zima · 2 shared papers, 2016 · strength 0.11
- Pavel Záruba · 1 shared paper, 2016 · strength 0.05
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.